The BMJ brings you interviews with the people who are shaping medicine and science around the world.
…
continue reading
Content provided by MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
The STREAM2 trial: How should we treat multi-drug resistant tuberculosis?
MP3•Episode home
Manage episode 358852991 series 1631392
Content provided by MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
For World TB Day, this episode explores the global burden of tuberculosis (TB) and how growing antibiotic resistance can complicate treatment options. Andrew Nunn, a Professor of Epidemiology, discusses his work on the STREAM2 trial, which investigated how treatment for multi-drug resistant TB could be shortened and made more acceptable for patients. Further information is available on the STREAM Stage 2 study page at www.mrcctu.ac.uk and results from STREAM2 are published open access in The Lancet. For questions or feedback on the series, message us at [email protected] For more information and to access the transcript: http://bit.ly/3TDnz24 As a listener, your opinion is very valuable to us. Please help us to improve the podcast in future by filling in this short survey: https://forms.office.com/e/PjfjQ5Mn6g
…
continue reading
25 episodes
MP3•Episode home
Manage episode 358852991 series 1631392
Content provided by MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
For World TB Day, this episode explores the global burden of tuberculosis (TB) and how growing antibiotic resistance can complicate treatment options. Andrew Nunn, a Professor of Epidemiology, discusses his work on the STREAM2 trial, which investigated how treatment for multi-drug resistant TB could be shortened and made more acceptable for patients. Further information is available on the STREAM Stage 2 study page at www.mrcctu.ac.uk and results from STREAM2 are published open access in The Lancet. For questions or feedback on the series, message us at [email protected] For more information and to access the transcript: http://bit.ly/3TDnz24 As a listener, your opinion is very valuable to us. Please help us to improve the podcast in future by filling in this short survey: https://forms.office.com/e/PjfjQ5Mn6g
…
continue reading
25 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.